Lecanemab, a monoclonal antibody treatment marketed under the brand name Leqembi, represents a significant milestone in the clinical management of…
Read More
Breakthrough Research Identifies Molecular Death Complex Driving Alzheimers Disease and Potential Therapeutic Inhibitor
A collaborative research effort led by neurobiologist Professor Dr. Hilmar Bading at Heidelberg University has uncovered a fundamental molecular mechanism…
Read More
Molecular Breakthrough in Alzheimers Pathology Reveals Neurotoxic Death Complex as Key Therapeutic Target
A collaborative research effort led by neurobiologist Prof. Dr. Hilmar Bading at Heidelberg University’s Interdisciplinary Center for Neurosciences (IZN) has…
Read More
Scientific Study Unveils Five Biological Pathways Linking Microplastics to Neurodegenerative Diseases Like Alzheimers and Parkinsons
The global proliferation of plastic pollution has moved beyond an environmental crisis into the realm of a significant public health…
Read MoreYOU MAY HAVE MISSED
